↓ Skip to main content

Antitumor effect of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles on mice bearing breast cancer: a systemic toxicity assay

Overview of attention for article published in Tumor Biology, December 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter
3 X users
facebook
2 Facebook pages

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
53 Mendeley
Title
Antitumor effect of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles on mice bearing breast cancer: a systemic toxicity assay
Published in
Tumor Biology, December 2014
DOI 10.1007/s13277-014-2966-x
Pubmed ID
Authors

Raphael Cândido Apolinário Peixoto, Ana Luisa Miranda-Vilela, José de Souza Filho, Marcella Lemos’ Brettas Carneiro, Ricardo G. S. Oliveira, Matheus Oliveira da Silva, Aparecido R. de Souza, Sônia Nair Báo

Abstract

Breast cancer is one of the most prevalent cancer types among women. The use of magnetic fluids for specific delivery of drugs represents an attractive platform for chemotherapy. In our previous studies, it was demonstrated that maghemite nanoparticles coated with rhodium (II) citrate (Magh-Rh2Cit) induced in vitro cytotoxicity and in vivo antitumor activity, followed by intratumoral administration in breast carcinoma cells. In this study, our aim was to follow intravenous treatment to evaluate the systemic antitumor activity and toxicity induced by these formulations in Balb/c mice bearing orthotopic 4T1 breast carcinoma. Female Balb/c mice were evaluated with regard to toxicity of intravenous treatments through analyses of hemogram, serum levels of alanine aminotransferase, iron, and creatinine and liver, kidney, and lung histology. The antitumor activity of rhodium (II) citrate (Rh2Cit), Magh-Rh2Cit, and maghemite nanoparticles coated with citrate (Magh-Cit), used as control, was evaluated by tumor volume reduction, histology, and morphometric analysis. Magh-Rh2Cit and Magh-Cit promoted a significant decrease in tumor area, and no experimental groups presented hematotoxic effects or increased levels of serum ALT and creatinine. This observation was corroborated by the histopathological examination of the liver and kidney of mice. Furthermore, the presence of nanoparticles was verified in lung tissue with no morphological changes, supporting the idea that our nanoformulations did not induce toxicity effects. No studies about the systemic action of rhodium (II) citrate-loaded maghemite nanoparticles have been carried out, making this report a suitable starting point for exploring the therapeutic potential of these compounds in treating breast cancer.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 2%
Unknown 52 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 17%
Student > Doctoral Student 8 15%
Student > Ph. D. Student 7 13%
Student > Bachelor 6 11%
Researcher 5 9%
Other 8 15%
Unknown 10 19%
Readers by discipline Count As %
Chemistry 10 19%
Agricultural and Biological Sciences 7 13%
Pharmacology, Toxicology and Pharmaceutical Science 6 11%
Biochemistry, Genetics and Molecular Biology 5 9%
Medicine and Dentistry 5 9%
Other 9 17%
Unknown 11 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 November 2015.
All research outputs
#7,138,767
of 22,776,824 outputs
Outputs from Tumor Biology
#358
of 2,622 outputs
Outputs of similar age
#99,278
of 353,119 outputs
Outputs of similar age from Tumor Biology
#19
of 164 outputs
Altmetric has tracked 22,776,824 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 2,622 research outputs from this source. They receive a mean Attention Score of 2.2. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,119 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 164 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.